Immunoexpression of neurofibromin, S-100 protein, and Leu-7 and mutation analysis of the NF1 gene at codon 1423 in Osteofibrous Dysplasia

Human Pathology

Volumn 32, Issue 11, 2001, Pages 1245-1251

  Sakamoto, Akio ^a   Oda, Yoshinao ^a   Oshiro, Yumi ^a   Tamiya, Sadafumi ^a   Iwamoto, Yukihide ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Leu 7; Neurofibromin, S 100 protein; NF1 gene; Osteofibrous dysplasia

Indexed keywords

CD57 ANTIGEN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; NEUROFIBROMIN; PROTEIN S 100; RAS PROTEIN;

ARTICLE; CONTROLLED STUDY; FIBROUS DYSPLASIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROFIBROMATOSIS; POLYMERASE CHAIN REACTION; SCHWANN CELL; SINGLE STRAND CONFORMATION POLYMORPHISM; SPINDLE CELL; TUMOR SUPPRESSOR GENE;

EID: 0035179225     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.28954     Document Type: Article

References (39)

1. A genetic study of von Recklinghausen neurofibromatosis in south east Wales: I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity
2. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes
3. Identification of the neurofibromatosis type 1 gene product
4. The neurofibromatosis type 1 gene encodes a protein related to GAP
5. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
6. Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation
7. NF1: A prevalent cause of tumorigenesis in human cancers?
8. Ossifying fibroma of long bone: Its distinction from fibrous dysplasia and its association with adamantinoma of long bone
9. Adamantinoma of long bones: A clinicopathologic study of 85 cases
10. Neurofibromatosis 1 and osseous fibrous dysplasia in a family
11. Congenital pseudathrosis of the tibia: History, etiology, classification, and epidemiologic data
12. The possible relationship of neurofibromatosis, congenital pseudoarthrosis and fibrous dysplasia
13. Congenital pseudoarthrosis of the tibia
14. The differential diagnosis of congenital pseudarthrosis of the tibia
15. Osteofibrous dysplasia of the tibia and fibula
16. Pathology of bone lesions associated with congenital pseudarthrosis of the leg
17. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction with precocious puberty in females
18. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia
19. 201 codon: Polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues
20. Somatic mutations in the neurofibromatosis 1 gene in human tumors
21. Ras regulation: NF is enough of GAP
22. Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation
23. Aggressive bone tumorous lesion in infancy: Osteofibrous dysplasia of the tibia and fibula
24. S-100 protein immunostaining in the differential diagnosis of chondroblastoma
25. Mechanism of pain in osteoid osteomas: An immunohistochemical study
26. Osteoid osteoma: The uniquely innervated bone tumor
27. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumor suppressor gene hypothesis
28. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF 1 tumor suppressor gene in vivo and in vitro
29. Absence of mutation at the GAP-related domain of the neurofibromatosis type 1 gene in sporadic neurofibrosarcomas and other bone and soft tissue sarcomas
30. Congenital ossifying fibroma (osteofibrous dysplasia) of the tibia-A case report
31. On theory and practice of congenital pseudarthroses of the lower leg
32. Clonal chromosomal abnormalities in osteofibrous dysplasia: Implications for histopathogenesis and its relationship with adamantinoma
33. Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of tibia and fibula: An immunohistochemical study correlated to histogenesis
34. Osteofibrous dysplasia-like adamantinoma of bone: A report of five cases with immunohistochemical and ultrastructural studies
35. Morphologic diversity of long bone adamantinoma: The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia
36. Osteofibrous dysplasia: Clinicopathologic study of 80 cases
37. Morphologic diversity of long bone adamantinoma: The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia
38. Ossifying fibroma of long bone: Its distinction from fibrous dysplasia and its association with adamantinoma of long bone
39. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to expressions of c-fos and c-jun products and bone matrix proteins: A clinicopathological review and immunohistochemical study of c-fos, c-jun, type 1 collagen, osteonectin, osteopontin and osteocalcin